Hospitals

Cleveland Clinic’s Steven Nissen: The need for head-to-head drug trials

Dr. Steven Nissen, chair of Cleveland Clinic’s cardiovascular medicine department, talks about why head-to-head clinical trials of competing drugs and devices would benefit patients. “In medicine, we have many alternative therapies for patients,” he said. “What we need to know to take good care of our patients is which of these therapies is best.” Nissen […]

By Brandon Glenn on October 05, 2011

Dr. Steven Nissen, chair of Cleveland Clinic’s cardiovascular medicine department, talks about why head-to-head clinical trials of competing drugs and devices would benefit patients.

“In medicine, we have many alternative therapies for patients,” he said. “What we need to know to take good care of our patients is which of these therapies is best.”

Nissen spoke at the Cleveland Clinic Medical Innovation Summit.

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.